These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 22923048

  • 21. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
    Kalkandelen KT, Doluca Dereli M.
    Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
    [Abstract] [Full Text] [Related]

  • 22. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 23. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C, Hampe IAI, Hertlein T, Ohlsen K, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.
    Liu JY, Shi C, Wang Y, Li WJ, Zhao Y, Xiang MJ.
    Res Microbiol; 2015 Apr; 166(3):153-61. PubMed ID: 25748216
    [Abstract] [Full Text] [Related]

  • 25. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
    Maheronnaghsh M, Teimoori A, Dehghan P, Fatahinia M.
    J Clin Lab Anal; 2022 Feb; 36(2):e24208. PubMed ID: 34997991
    [Abstract] [Full Text] [Related]

  • 26. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
    Wang Y, Liu JY, Shi C, Li WJ, Zhao Y, Yan L, Xiang MJ.
    Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
    [Abstract] [Full Text] [Related]

  • 27. Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1, Upc2, and Cap1 in Candida albicans.
    Schubert S, Barker KS, Znaidi S, Schneider S, Dierolf F, Dunkel N, Aïd M, Boucher G, Rogers PD, Raymond M, Morschhäuser J.
    Antimicrob Agents Chemother; 2011 May; 55(5):2212-23. PubMed ID: 21402859
    [Abstract] [Full Text] [Related]

  • 28. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
    Choi MJ, Won EJ, Shin JH, Kim SH, Lee WG, Kim MN, Lee K, Shin MG, Suh SP, Ryang DW, Im YJ.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550
    [Abstract] [Full Text] [Related]

  • 29. UPC2 mutations and development of azole resistance in Candida albicans hospital isolates from Lebanon.
    Fattouh N, Hdayed D, Hijazi A, Tokajian S, Khalaf RA.
    J Glob Antimicrob Resist; 2024 Sep; 38():341-348. PubMed ID: 39059553
    [Abstract] [Full Text] [Related]

  • 30. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
    Morais Vasconcelos Oliveira J, Conceição Oliver J, Latércia Tranches Dias A, Barbosa Padovan AC, Siqueira Caixeta E, Caixeta Franco Ariosa M.
    Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
    [Abstract] [Full Text] [Related]

  • 31. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
    Gulat S, Doluca Dereli M.
    Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
    [Abstract] [Full Text] [Related]

  • 32. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
    Fattouh N, Hdayed D, Geukgeuzian G, Tokajian S, Khalaf RA.
    Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness in Candida albicans.
    Sasse C, Dunkel N, Schäfer T, Schneider S, Dierolf F, Ohlsen K, Morschhäuser J.
    Mol Microbiol; 2012 Nov; 86(3):539-56. PubMed ID: 22924823
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance.
    Branco J, Ola M, Silva RM, Fonseca E, Gomes NC, Martins-Cruz C, Silva AP, Silva-Dias A, Pina-Vaz C, Erraught C, Brennan L, Rodrigues AG, Butler G, Miranda IM.
    Clin Microbiol Infect; 2017 Aug; 23(8):575.e1-575.e8. PubMed ID: 28196695
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D, Kuchler K, Ischer F, Pagani JL, Monod M, Bille J.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.